rs2304566

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000542.5(SFTPB):​c.856+29A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.252 in 1,601,346 control chromosomes in the GnomAD database, including 53,247 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.21 ( 3611 hom., cov: 33)
Exomes 𝑓: 0.26 ( 49636 hom. )

Consequence

SFTPB
NM_000542.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -1.39

Publications

11 publications found
Variant links:
Genes affected
SFTPB (HGNC:10801): (surfactant protein B) This gene encodes the pulmonary-associated surfactant protein B (SPB), an amphipathic surfactant protein essential for lung function and homeostasis after birth. Pulmonary surfactant is a surface-active lipoprotein complex composed of 90% lipids and 10% proteins which include plasma proteins and apolipoproteins SPA, SPB, SPC and SPD. The surfactant is secreted by the alveolar cells of the lung and maintains the stability of pulmonary tissue by reducing the surface tension of fluids that coat the lung. The SPB enhances the rate of spreading and increases the stability of surfactant monolayers in vitro. Multiple mutations in this gene have been identified, which cause pulmonary surfactant metabolism dysfunction type 1, also called pulmonary alveolar proteinosis due to surfactant protein B deficiency, and are associated with fatal respiratory distress in the neonatal period. Alternatively spliced transcript variants encoding the same protein have been identified.[provided by RefSeq, Feb 2010]
SFTPB Gene-Disease associations (from GenCC):
  • surfactant metabolism dysfunction, pulmonary, 1
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 2-85663635-T-C is Benign according to our data. Variant chr2-85663635-T-C is described in ClinVar as Benign. ClinVar VariationId is 1224829.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.263 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SFTPBNM_000542.5 linkc.856+29A>G intron_variant Intron 7 of 10 ENST00000519937.7 NP_000533.4 P07988D6W5L6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SFTPBENST00000519937.7 linkc.856+29A>G intron_variant Intron 7 of 10 1 NM_000542.5 ENSP00000428719.2 P07988

Frequencies

GnomAD3 genomes
AF:
0.209
AC:
31693
AN:
151850
Hom.:
3605
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.130
Gnomad AMI
AF:
0.218
Gnomad AMR
AF:
0.181
Gnomad ASJ
AF:
0.214
Gnomad EAS
AF:
0.0979
Gnomad SAS
AF:
0.236
Gnomad FIN
AF:
0.224
Gnomad MID
AF:
0.226
Gnomad NFE
AF:
0.266
Gnomad OTH
AF:
0.215
GnomAD2 exomes
AF:
0.212
AC:
47449
AN:
223718
AF XY:
0.221
show subpopulations
Gnomad AFR exome
AF:
0.127
Gnomad AMR exome
AF:
0.120
Gnomad ASJ exome
AF:
0.216
Gnomad EAS exome
AF:
0.0894
Gnomad FIN exome
AF:
0.213
Gnomad NFE exome
AF:
0.266
Gnomad OTH exome
AF:
0.224
GnomAD4 exome
AF:
0.257
AC:
371821
AN:
1449378
Hom.:
49636
Cov.:
35
AF XY:
0.257
AC XY:
184678
AN XY:
719940
show subpopulations
African (AFR)
AF:
0.127
AC:
4220
AN:
33306
American (AMR)
AF:
0.130
AC:
5525
AN:
42506
Ashkenazi Jewish (ASJ)
AF:
0.215
AC:
5573
AN:
25872
East Asian (EAS)
AF:
0.0815
AC:
3196
AN:
39218
South Asian (SAS)
AF:
0.239
AC:
20197
AN:
84586
European-Finnish (FIN)
AF:
0.206
AC:
10761
AN:
52132
Middle Eastern (MID)
AF:
0.235
AC:
1347
AN:
5742
European-Non Finnish (NFE)
AF:
0.277
AC:
306389
AN:
1106084
Other (OTH)
AF:
0.244
AC:
14613
AN:
59932
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
16562
33125
49687
66250
82812
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10234
20468
30702
40936
51170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.209
AC:
31703
AN:
151968
Hom.:
3611
Cov.:
33
AF XY:
0.207
AC XY:
15377
AN XY:
74244
show subpopulations
African (AFR)
AF:
0.130
AC:
5388
AN:
41470
American (AMR)
AF:
0.181
AC:
2760
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.214
AC:
742
AN:
3468
East Asian (EAS)
AF:
0.0977
AC:
502
AN:
5136
South Asian (SAS)
AF:
0.236
AC:
1131
AN:
4794
European-Finnish (FIN)
AF:
0.224
AC:
2367
AN:
10576
Middle Eastern (MID)
AF:
0.226
AC:
66
AN:
292
European-Non Finnish (NFE)
AF:
0.266
AC:
18103
AN:
67944
Other (OTH)
AF:
0.212
AC:
446
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1277
2554
3832
5109
6386
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
344
688
1032
1376
1720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.210
Hom.:
1335
Bravo
AF:
0.200
Asia WGS
AF:
0.166
AC:
577
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Dec 31, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Surfactant metabolism dysfunction, pulmonary, 1 Benign:1
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
1.7
DANN
Benign
0.64
PhyloP100
-1.4
PromoterAI
-0.00030
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2304566; hg19: chr2-85890758; COSMIC: COSV60894519; COSMIC: COSV60894519; API